Open AccessTherapy of candidosis vulvovaginitis at pregnancy
Author(s) -
I. A. Simchera,
Е. Ф. Кира,
V. M. Dobrynin
Publication year - 1998
Publication title -
journal of obstetrics and women s diseases
Language(s) - English
Resource type - Journals
eISSN - 1684-0461
pISSN - 1683-9366
DOI - 10.17816/jowd86951
Subject(s) - medicine , pregnancy , vulvitis , obstetrics , dermatology , gynecology , vaginitis , genetics , biology
Clinical effectiveness gyno-pevaryl (GP) is investigated at treatment acute (30 women) and chronic (38 patients) candidosis vulvovaginitis in the period of pregnancy. In an end of course of treatment GP clinical and laboratory the confirmed recovery is marked in the first group at 80.0 % patients, in the second and the third - at 76.3 % patients. Gynopevaryl is an effective preparation for local treatment acute and chronic candidosis vulvovaginitis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom